[go: up one dir, main page]

DE60101859D1 - Pinolensäure gegen Diabetes - Google Patents

Pinolensäure gegen Diabetes

Info

Publication number
DE60101859D1
DE60101859D1 DE60101859T DE60101859T DE60101859D1 DE 60101859 D1 DE60101859 D1 DE 60101859D1 DE 60101859 T DE60101859 T DE 60101859T DE 60101859 T DE60101859 T DE 60101859T DE 60101859 D1 DE60101859 D1 DE 60101859D1
Authority
DE
Germany
Prior art keywords
diabetes
pinolenic acid
acid
pinolenic
glyceride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60101859T
Other languages
English (en)
Other versions
DE60101859T2 (de
Inventor
Louise Brown
Frederick William Cain
Martin Richard Green
Julia Sarah Rogers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever NV
Original Assignee
Unilever NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever NV filed Critical Unilever NV
Publication of DE60101859D1 publication Critical patent/DE60101859D1/de
Application granted granted Critical
Publication of DE60101859T2 publication Critical patent/DE60101859T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60101859T 2000-02-24 2001-02-12 Pinolensäure gegen Diabetes Expired - Lifetime DE60101859T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00301440 2000-02-24
EP00301440 2000-02-24

Publications (2)

Publication Number Publication Date
DE60101859D1 true DE60101859D1 (de) 2004-03-04
DE60101859T2 DE60101859T2 (de) 2004-12-30

Family

ID=31197762

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60101859T Expired - Lifetime DE60101859T2 (de) 2000-02-24 2001-02-12 Pinolensäure gegen Diabetes

Country Status (4)

Country Link
EP (1) EP1129711B1 (de)
AT (1) ATE258435T1 (de)
DE (1) DE60101859T2 (de)
ES (1) ES2213666T3 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1302114A3 (de) * 2001-10-16 2004-01-14 Loders Croklaan B.V. Mischungen zur Förderung der Glucoseaufnahme
GB0311081D0 (en) 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
WO2005018632A1 (en) 2003-08-18 2005-03-03 Btg International Limited Treatment of neurodegenerative conditions
WO2005051103A1 (en) * 2003-10-30 2005-06-09 Loders Croklaan B.V. Food product comprising an extract from pine needles
GB0514463D0 (en) * 2005-01-31 2005-08-17 Loders Croklaan Bv Use of pinolenic acid
GB0504362D0 (en) 2005-03-02 2005-04-06 Btg Int Ltd Cytokine modulators
EP2090172A1 (de) * 2007-10-29 2009-08-19 Lipid Nutrition B.V. Teigzusammensetzung
WO2009056251A1 (en) * 2007-10-29 2009-05-07 Lipid Nutrition B.V. Soup or sauce composition and process for its production
WO2016205754A1 (en) 2015-06-19 2016-12-22 University Of Southern California Compositions and methods for modified nutrient delivery
WO2016205701A1 (en) 2015-06-19 2016-12-22 University Of Southern California Enteral fast access tract platform system

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6158536A (ja) * 1984-08-31 1986-03-25 Nippon Oil & Fats Co Ltd 栄養組成物
US5902726A (en) * 1994-12-23 1999-05-11 Glaxo Wellcome Inc. Activators of the nuclear orphan receptor peroxisome proliferator-activated receptor gamma
DE19503993A1 (de) * 1995-02-08 1996-08-14 Johann Friedrich Dr Med Desaga Verwendung eines Produktes zur enteralen Versorgung mit Lebensmittelinhaltsstoffen oder Arzneimittelinhaltsstoffen
FR2756465B1 (fr) * 1996-12-03 1999-02-19 D A Noste Additif alimentaire, composition cosmetique et medicament a base d'huile de graines de pin
US6329000B1 (en) * 1997-01-27 2001-12-11 Ling Ji Extract of pine needle and the use thereof
ATE323480T1 (de) * 1999-09-30 2006-05-15 Loders Croklaan Bv Zusammensetzungen, enthaltend pinolensäure sowie deren verwendung zur gesundheitserhaltung

Also Published As

Publication number Publication date
EP1129711B1 (de) 2004-01-28
EP1129711A3 (de) 2001-09-12
ATE258435T1 (de) 2004-02-15
EP1129711A2 (de) 2001-09-05
DE60101859T2 (de) 2004-12-30
ES2213666T3 (es) 2004-09-01

Similar Documents

Publication Publication Date Title
PL2436275T3 (pl) Kompozycja lipidowa dla poprawy funkcji mózgu
ZA200909227B (en) Food composition for prodromal dementia patients
IL183401A0 (en) Compositions comprising ornithine and phenylacetate of phenylbutyrate for treating hepatic encephalopathy
ATE406882T1 (de) Zusammensetzungen zur normalisierung des zirkadianen rythmus
MX2007011031A (es) Tratamiento con estatina y acidos grasos omega-3 y un producto de combinacion de los mismos.
WO2008036353A3 (en) Omega-3 diglyceride emulsions
ATE497766T1 (de) Verringerung von schwindel, einer nebenwirkung im zusammenhang mit einer pirfenidon-therapie
DE60101859D1 (de) Pinolensäure gegen Diabetes
PT1088552E (pt) Composicoes contendo acido pinolenico e sua utilizacao como componente na saude
ATE306263T1 (de) Zusammensetzungen zur verabreichung eines cyclooxygenase-2-hemmers an tiere
WO2007018588A8 (en) Stable pharmaceutical composition comprising linezolid form iv
BR0213124A (pt) Alimentos para animais incluindo ativos e métodos de uso dos mesmos
EP2229957A3 (de) Stabilisierung von wässrigen Zusammensetzungen von 18F-markierter 2-Fluoro-2-deoxy-D-Glukose mit Ethanol
WO2004089992A8 (ja) 改質アラビアガムおよびその用途
HUP0200511A3 (en) Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid
ATE443515T1 (de) Omega-3-fettsäuren und omega-6-fettsäuren enthaltende zusammensetzung
WO2008063772A3 (en) Resolvin d series and protectin d1 mitigate acute kidney injury
SI1651194T1 (sl) Stabilni farmacevtski sestavki za nadzorovano sproščanje, ki vsebujejo fenofibrat in pravastatin
WO2005053669A8 (fr) Utilisation des acides gras polyinsatures omega 3 dans l'apnee du sommeil
EP1269991A3 (de) Topische Zusammensetzung die Ethyllinoleat und/oder Triethylzitrat mit Synergisten
PL1799027T3 (pl) Rośliny o nasionach niezawierających nasyconych kwasów tłuszczowych lub o zmniejszonej zawartości kwasów tłuszczowych i olej pozyskany z takich nasion
BRPI0506456A (pt) composição de alimento com sabor
WO2003037375A1 (fr) Substance d'induction de cytokine et instrument d'induction de cytokine
ATE485058T1 (de) Zusammensetzung enthaltend eine kombination aus einem ppar-alpha, pravastatin und polyglykolisiertem glyzerid
ATE456308T1 (de) Liponsäure-konzentrat

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: MEISSNER, BOLTE & PARTNER GBR, 80538 MUENCHEN